Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Non-Current Assets (2018 - 2025)

Historic Non-Current Assets for TransMedics (TMDX) over the last 8 years, with Q3 2025 value amounting to $333.0 million.

  • TransMedics' Non-Current Assets rose 1362.69% to $333.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 3396.34%. This contributed to the annual value of $306.9 million for FY2024, which is 5704.76% up from last year.
  • Latest data reveals that TransMedics reported Non-Current Assets of $333.0 million as of Q3 2025, which was up 1362.69% from $332.4 million recorded in Q2 2025.
  • In the past 5 years, TransMedics' Non-Current Assets ranged from a high of $333.0 million in Q3 2025 and a low of $4.7 million during Q1 2021
  • In the last 5 years, TransMedics' Non-Current Assets had a median value of $20.0 million in 2023 and averaged $133.6 million.
  • As far as peak fluctuations go, TransMedics' Non-Current Assets tumbled by 929.3% in 2021, and later surged by 114874.53% in 2024.
  • Quarter analysis of 5 years shows TransMedics' Non-Current Assets stood at $9.8 million in 2021, then surged by 95.34% to $19.2 million in 2022, then surged by 916.45% to $195.4 million in 2023, then skyrocketed by 57.05% to $306.9 million in 2024, then grew by 8.53% to $333.0 million in 2025.
  • Its last three reported values are $333.0 million in Q3 2025, $332.4 million for Q2 2025, and $331.6 million during Q1 2025.